Perrigo receives FDA approval for generic Monistat-1 Combination Pack
ALLEGAN, Mich. Perrigo on Thursday announced that it has received final approval from the Food and Drug Administration for its abbreviated new drug application for over-the-counter miconazole nitrate vaginal cream and suppository, a generic to Monistat-1 Combination Pack, and expects to begin shipping immediately.
Annual sales of Monistat-1 totaled approximately $90 million and is indicated for the treatment of vaginal yeast infections and for the relief of external itching and irritation they cause, Perrigo reported.
Perrigo was the first to file an ANDA containing a Paragraph IV certification, and the resulting patent litigation filed by Johnson & Johnson previously was dismissed. Perrigo’s approval included 180 days of generic marketing exclusivity.
Zymaderm now available at Walgreens
BOISE, Idaho Naturopathix on Wednesday announced that its homeopathic remedy Zymaderm for relief of molluscum contagiosum symptoms has expanded distribution through national retailer Walgreens from Amazon.com and independents.
Molluscum contagiosum is a contagious skin infection caused by a virus that is a member of the poxvirus family. Symptoms can include raised, warty lesions, and the infection accounts for approximately 1% of all diagnoses of skin disorders, Naturopathix reported.
JDRF honors Roche with Chancellor’s Award
INDIANAPOLIS A maker of blood-glucose meters, infusion pumps and other diabetes management tools was awarded by the Juvenile Diabetes Research Foundation for its long-standing corporate partnership with the organization.
Roche was given the Chancellor’s Award at JDRF’s annual conference in Washington, D.C., and was noted as “an exceptional partner in the education and management of diabetes.” Roche and JDRF work together on the Bag of Hope program, which provides education materials on juvenile diabetes and a free Accu-Chek blood-glucose meter. The bags contain products and materials valued at about $100, which are distributed to families by local Roche and JDRF representatives.
Since 2004, Roche has committed almost $10 million to the Bag of Hope program.
“Roche is an exceptional partner in the education and management of diabetes. During the past several years, the Bag of Hope program has become the cornerstone of our outreach program to families with newly diagnosed children, and we thank Roche for its continued funding of this incredibly important educational initiative,” said Courtney Davies, national director of corporate relations at JDRF.